Contraception clinical trials at UC Davis

3 in progress, 1 open to eligible people

Showing trials for

  • FemBloc Permanent Birth Control

    “FemBloc is an investigational, in-office permanent birth control that does not involve surgery, incisions or implants.”

    open to eligible females ages 21-50

    Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.

    Sacramento, California and other locations

  • PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception

    Sorry, in progress, not accepting new patients

    This is a Phase I multicenter, open-label, dose-ranging, three-dose PK and PD study of injectable LB administered as an IM or SQ injection at 40 mg, and subsequently at 50mg SQ and then 60 mg SQ depending on the preliminary pharmacokinetic and pharmacodynamic results obtained with 40 mg dosing.

    Davis, California and other locations

  • Tolerability of LevoCept

    Sorry, not yet accepting patients

    To assess the contraceptive efficacy (prevention of pregnancy) of LevoCept

    Sacramento, California and other locations

Our lead scientists for Contraception research studies include .

Last updated: